Also, SLC1A4 and other transporters such as SLC7A8, SLC38A1, and SLC38A2 were detected as putative targets of an anti-cancer drug named Benzylserine in breast cancer, which their uptake activity is directly inhibited by this drug [37]. This evidence concerns the gene SLC1A4 and breast cancer.